Why the study?
The Minimal Model method for the intravenous glucose tolerance test has been argued to overestimate glucose effectiveness or underestimate insulin sensitivity in some cases.
Does a novel IVGTT model including interstitial insulin improve the assessment of glucose effectiveness and insulin sensitivity compared to the Minimal Model?
Does a novel IVGTT model including interstitial insulin improve the assessment of glucose effectiveness and insulin sensitivity compared to the Minimal Model?
A novel mathematical model for IVGTT incorporating interstitial insulin may provide more accurate assessments of glucose effectiveness and insulin sensitivity than the traditional Minimal Model.
No takes yet. Share an insight, caveat, or question.
May refine IVGTT estimates of glucose effectiveness and insulin sensitivity in subgroups; leaves open prospective validation before clinical adoption.
Jin et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: